GWB 20.41 Great Western Bancorp Inc. $GWB Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
GWB 20.41 Great Western Bancorp Inc. $GWB Hit a 52 week high of 20.41 Currently at 20.41 +0.06 +0.29% With a day low of 20.18 and a total volume of 26,722.

GWB Great Western Bancorp Inc. Recent Headline News

Great Western Bancorp, Inc. Announces Fiscal Year End 2014 Earnings and Conference Call Date
Business Wire - Thu Nov 06, 8:00AM CST
Great Western Bancorp, Inc. (NYSE:GWB) announced today that it will release its financial results for the fiscal year ended September 30, 2014 on Thursday, November 20, 2014. The results will be discussed by Great Western's President and Chief Executive Officer, Ken Karels, and Chief Financial Officer, Peter Chapman, during a conference call at 7:30 a.m. CT / 8:30 a.m. ET.
GWB: 20.06 (-0.29)

InsiderInsights.com Daily Round Up 10/20/14: REGN, OPK, AGCO, HSON
InsiderInsights - at Seeking Alpha - Tue Oct 21, 8:35AM CDT

ZF: 15.16 (+0.02), AGCO: 45.15 (-0.09), HSON: 3.44 (+0.04), NNVC: 3.60 (-0.02), CMN: 41.73 (+0.53), GOOG: 549.25 (+1.76), HPQ: 36.79 (-0.11), RPXC: 14.01 (+0.06), ZTR: 13.86 (+0.03), UNFI: 73.43 (+0.40), OPK: 8.50 (-0.13), ARDC: 16.72 (+0.04), GOOGL: 560.30 (+2.07), GIS: 51.01 (+0.14), GWB: 20.06 (-0.29), REGN: 396.55 (+10.58), RFP: 18.70 (-0.13), URI: 113.02 (-0.68)

Great Western Bancorp closes IPO and declares full exercise of underwriters' option
M2 - Tue Oct 21, 3:28AM CDT
The holding company of Great Western Bank, Great Western Bancorp Inc (NYSE:GWB) closed its initial public offering (IPO) of 18,400,000 shares or 31.8% of its common stock, combined with the full exercise of the underwriters' over allotment option for 2,400,000 additionally shares, it stated on Monday.
GWB: 20.06 (-0.29)

Great Western Bancorp, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Business Wire - Mon Oct 20, 1:07PM CDT
Great Western Bancorp, Inc. (NYSE:GWB) announced today that it has completed its initial public offering of 18,400,000 shares, or 31.8%, of its common stock, which includes the full exercise of the underwriters' option to purchase an additional 2,400,000 shares. GWB's common stock began trading on the New York Stock Exchange on October 15, 2014, under the ticker symbol "GWB". The shares were offered by an affiliate of National Australia Bank.
DB: 30.03 (+0.03), GWB: 20.06 (-0.29)

U.S. IPO Weekly Recap: 5 IPOs Achieve Moderate Gains During The Market Slide And A Biotech Rejection
Renaissance Capital IPO Research - at Seeking Alpha - Sun Oct 19, 12:54PM CDT
Five initial public offerings collectively raised $1.3 billion during the past week, bringing the year's total to 228 IPOs and $73.5 billion raised, a 35% increase over this time last year by deal count and an 84% increase by proceeds. The S&P...
DM: 34.48 (+0.86), FWP: 23.18 (-0.03), ATRA: 28.23 (+1.81), ZAYO: 23.04 (-0.48), GWB: 20.06 (-0.29)

IPO Stock Watch: Zayo Group Up 16% In Tough IPO Field
at Investor's Business Daily - Fri Oct 17, 6:07PM CDT
In a recently weakened market for IPOs, Zayo Group Holdings rose 16% on its first day of trading Friday. The caveat is that Zayo Group (ZAYO), a provider of high-bandwidth, fiber-optic infrastructure in the U.S. and Europe, did not get all that it...
XENE: 17.74 (+1.74), ZAYO: 23.04 (-0.48), GWB: 20.06 (-0.29), BABA: 114.57 (-4.58)

IPO Stock Watch: Biotech Forward Pharma Falls On IPO
at Investor's Business Daily - Wed Oct 15, 3:06PM CDT
Forward Pharma, the largest biotech IPO this year, tanked on its first day of trading. Denmark-based Forward Pharma (FWP) raised $221 million by pricing 10.5 million shares at 21, the midpoint of its 20-22 range. The stock was trading near 17.50,...
DM: 34.48 (+0.86), BIIB: 326.89 (-0.98), KITE: 42.11 (-0.75), FWP: 23.18 (-0.03), XENE: 17.74 (+1.74), ATRA: 28.23 (+1.81), VBAY: (), GWB: 20.06 (-0.29)

Great Western Bancorp prices IPO of 16m common stock at USD18 per share
M2 - Wed Oct 15, 5:14AM CDT
Great Western Bancorp Inc (GWB), the holding company of Great Western Bank, disclosed on Wednesday that it has priced its initial public offering (IPO) of 16,000,000 shares or 27.6% of its common stock at USD18 per share.
GWB: 20.06 (-0.29)

IPO Preview: Great Western Bancorp
IPOdesktop - at Seeking Alpha - Wed Oct 15, 1:41AM CDT
Based in Sioux Falls, SD, Great Western Bancorp (Pending: GWB ) scheduled a $360 million IPO on the NYSE with a market capitalization of $1.3 billion at a price range midpoint of $22.50 for Wednesday, Oct. 15, 2014. The full IPO calendar is...
GWB: 20.06 (-0.29)

Great Western Bancorp, Inc. Announces Pricing of Initial Public Offering
Business Wire - Tue Oct 14, 6:22PM CDT
Great Western Bancorp, Inc. (GWB) announced today the pricing of the initial public offering of 16,000,000 shares, or 27.6%, of its common stock at a price of $18 per share. The shares have been offered by an affiliate of National Australia Bank. The selling shareholder has also granted the underwriters a 30-day option to purchase up to an additional 2,400,000 shares of GWB's common stock at the public offering price less the underwriting discount.
GWB: 20.06 (-0.29)

IPO Calendar: Biotech Companies Lead List Of 7 IPOs
at Investor's Business Daily - Mon Oct 13, 3:33PM CDT
In a big year for biotech IPOs, four more are scheduled to debut this week, including the year's largest -- Forward Pharma. Seven initial public offerings in total are expected this week, looking to raise a combined $1.7 billion. Forward Pharma (FWP)...
DM: 34.48 (+0.86), BIIB: 326.89 (-0.98), FWP: 23.18 (-0.03), KITE: 42.11 (-0.75), XENE: 17.74 (+1.74), MRK: 59.64 (+0.83), CFG: 23.96 (+0.01), ZAYO: 23.04 (-0.48), ATRA: 28.23 (+1.81), TEVA: 58.53 (+0.49), VBAY: (), GWB: 20.06 (-0.29)

Great Western Bancorp, Inc. Announces the Launch of an Initial Public Offering
Business Wire - Fri Oct 03, 6:00AM CDT
Great Western Bancorp, Inc. (GWB) announced today the launch of an initial public offering of 16,000,000 shares, which represents 27.6% of its outstanding common stock. The shares will be offered by an affiliate of National Australia Bank. The initial public offering price is currently estimated to be between US$21 and US$24. The selling shareholder will also grant the underwriters a 30-day option to purchase up to an additional 2,400,000 shares of GWB's common stock.
DB: 30.03 (+0.03), GWB: 20.06 (-0.29)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Doximity Lawsuit: Investors Face November Deadline

Updated Category News Views 1

Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...

Continue Reading
Teleste Unveils AI-Enhanced Rail Info Platform Innovation

Updated Category News Views 8

A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...

Continue Reading
Equity Alerts: Unraveling the Latest M&A Surprises

Updated Category News Views 5

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Continue Reading
ICAC's Landmark Program Strengthens Africa's Anti-Corruption Efforts

Updated Category News Views 9

A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 0

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
MOOV Emerges as a Strong AI Contender in Canada

Updated Category News Views 2

A New Pioneer in AI Business Transformation Who would’ve thought two companies merging into one could shake things up this much? Introducing MOOV—a fresh sprout in the Canadian AI scene that's setting out to redefine how businesses across North America get stuff done. By blending the robust AI chops of Moov AI with the strategic design finesse of Nurun, this firm’s...

Continue Reading
Compounded Meds: A Tailored Approach to Health Needs

Updated Category News Views 1

Custom Compounding: A Lifeline for Specific Needs Standard meds can sometimes feel like a one-size-fits-all shirt—sure it fits, but not comfortably for everyone. Enter the world of custom-compounded medications, where pharmacists like Laura Temple in Azle, Texas, create tailor-made solutions for patients. Think of it as fine-tuning the exact gear needed to climb that...

Continue Reading
WuXi Biologics Clinches Top ESG Honors in Award Circuit

Updated Category News Views 5

Pounding the ESG Pavement Every now and then, a story pops up that makes you wonder if the finance folks are finally waking up to what's been slap-you-in-the-face obvious: sustainability ain't just a fancy word for do-gooders anymore. It's the real ticket to the future, and WuXi Biologics (2269.HK) just snagged the top-honor Jade Award at The Asset Corporate...

Continue Reading
Advancing Mental Health in NICU Families: 2026 Event Insight

Updated Category News Views 6

Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...

Continue Reading
Highlight's Pulse Offers Real-Time Consumer Insights

Updated Category News Views 4

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...

Continue Reading

Top 5 Most Recently Viewed Articles

Definitive Healthcare Celebrated as a Top Boston Employer

Updated Category News Views 89

Definitive Healthcare Honored as a Premier Workplace Definitive Healthcare (NASDAQ: DH), a leading name in healthcare commercial intelligence, has recently earned prestigious recognition as one of the top employers in Boston. Celebrated by Built In’s 2025 Best Places to Work program, this accolade acknowledges businesses that foster exceptional workplace environments....

Continue Reading
Euroseas Q4 Earnings Beat Expectations: Key Insights

Updated Category News Views 157

Euroseas Earnings Report: Highlights and Performance The market loves a good surprise, and Euroseas just tossed a nice one into the mix with their latest earnings. Released February 25, 2026, at 08:00 AM, they’ve performed better than expected, snagging attention from investors ready for a ride. Earnings Overview Let’s cut to the chase: Euroseas reported an earnings...

Continue Reading
AstraZeneca and Daiichi Sankyo's Datroway: A Game Changer

Updated Category News Views 208

Introduction to Datroway's Impact on Breast Cancer Treatment AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo have announced remarkable findings from their TROPION-Breast02 Phase 3 trial for the drug Datroway (datopotamab deruxtecan), set to revolutionize the approach to treating triple-negative breast cancer (TNBC). This pharmaceutical collaboration showcases significant...

Continue Reading
Compute Exchange Revolutionizes AI Compute Market Dynamics

Updated Category News Views 806

Compute Exchange Revolutionizes AI Compute Market Dynamics Today marks a significant shift in the way AI compute resources are bought and sold with the introduction of Compute Exchange. This pioneering platform provides the first open exchange specifically designed for GPUs and various other compute resources, addressing the needs of both buyers and sellers in an...

Continue Reading
NuZee Stock Surges on Major Operational Changes and Leadership Shift

Updated Category News Views 88

NuZee Inc. Makes Headlines with Strategic Relocation NuZee, Inc. NUZE is witnessing a significant surge in its stock trading activity. The reason behind this movement is the recent announcement of the company relocating its U.S. operations from California to Florida. This strategic decision aims to bolster its operational efficiency and accessibility. Global Expansion...

Continue Reading